Clough Capital Partners Strengthens Healthcare Research Capabilities with the Addition of Dr. Noelle Tune

Advertisement

BEGIN ARTICLE PREVIEW:

BOSTON, Oct. 15, 2020 /PRNewswire/ — Clough Capital Partners L.P., an independent boutique manager of alternative investment strategies, is pleased to announce that Dr. Noelle Tune, MD has joined the firm as a Director and a healthcare research analyst. In this role, she will join the Clough Capital healthcare team led by Chief Executive Officer, co-Chief Investment Officer, and Portfolio Manager Michael Hearle.  
“Dr. Tune brings the valuable perspective of both a practicing physician with a deep research background and a proven institutional healthcare equity research analyst,” said Mr. Hearle. “Her experience on the frontlines in the fight against Covid-19 is tremendously helpful as we pursue themes around testing, therapeutics and services. We are excited about the contributions she will make to benefit our clients.”
Dr. Tune joins fellow Harvard alum, William Whelan, Managing Director and healthcare analyst; Partner and Portfolio Manager Robert Zdunczyk; and Hong Kong based Managing Director and research analyst Pricilla Chan on the Clough healthcare team led by Michael Hearle. Clough Capital invests across all six sub-sectors of healthcare, which include biotechnology, specialty pharma, medical technology, hospitals, large pharma and HMOs. Research activity is driven by a focus on finding assets at two major valuation inflection points: …

END ARTICLE PREVIEW

READ MORE FROM SOURCE ARTICLE